Skip to content

Public FDA record

Z-0776-2024: EvAir CPRSR Kit Upgrade: a) DISS/CEE 7/7 230V 50/60 HZ, Model Number M1230849; b) DISS/NEMA 5-15 115V

Recall record Z-0776-2024 for Datex-Ohmeda, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0776-2024
Company in FDA record
Datex-Ohmeda, Inc.
FDA classification date
Jan 30, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

GE HealthCare has become aware of elevated levels of formaldehyde when the EVair or EVair 03 (Jun-Air) optional compressors are used with the CARESCAPE R860 or Engstrm Carestation/Pro ventilators, respectively. These elevated results were observed in preliminary testing that was conducted at an elevated room temperature of 40oC (104oF), at the lowest possible flow condition of 2 L/min (worstcase, minimum bias flow with no additional ventilation), and all of the gas being supplied from the compressor (i.e., FiO2 of 21% / no supplemental oxygen). GE HealthCare is continuing to evaluate the root cause for these elevated levels of formaldehyde. While these test conditions are not representative of typical clinical use conditions,GE HealthCare is taking this action to further reduce the potential for patient exposure.

Source facts

Action
GE Healthcare issued an URGENT MEDICAL DEVICE CORRECTION notice to consignees on 12/29/2023. The notice explained the safety issue with the device and requested the following actions be taken: GE HealthCare recommends that the EVair and EVair 03 (Jun-Air) compressors are not used to supply air to ventilators for neonatal and infant patients (0-2 years of age). Since the elevated levels of formaldehyde are observed when the compressors are used at higher room temperatures, GE HealthCare is also lowering the maximum room air temperature for operation of the compressors from 40oC (104oF) to 30oC (86oF). Please ensure all potential users in your facility are made aware of this safety notification and the recommended actions. Retain this document and the Addendum to the user instructions for your records. Please keep a copy of the Addendum available near the areas where the compressors are used. GE sent an updated communication to consignees on 10/11/2024 stating the following: EVair Compressors: The recommended actions indicated in the previous letter for EVair Compressors no longer apply, as such: 1. The EVair Compressors can be used to supply air to CARESCAPE R860 ventilators for all patient populations, including neonatal and infant patients (0-2 years of age). 2. The EVair Compressor can be used in a room with maximum air temperature of 40oC (104F). EVair 03 (Jun-Air) Compressors: For the EVair 03 (Jun-Air) compressors (at End of Service Support): If you choose to continue to use these, the instructions in the 12/29/2023 letter continue to apply: 1. GE HealthCare recommends that the EVair 03 (Jun-Air) compressors are not used to supply air to ventilators for neonatal and infant patients (0-2 years of age). 2. GE HealthCare recommends that these compressors are used at a maximum room air temperature of 30oC (86oF). Contact for questions/concerns: GE HealthCare Service at 1-800-437-1171 or your local Service Representative.
Initiated
2023-12-29
Root cause
Component design/selection
Distribution
Worldwide
Recall number
Z-0776-2024
Recall status
Open, Classified
CDRH record ID
205310
FDA classified
2024-01-30
Recall event number
93715

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗